Yoshiharu Suzuki

Dr. Yoshiharu Suzuki

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YSYoshiharu Suzuki
Yoshiharu Suzuki
TYTakuya Yoshihashi
Takuya Yoshihashi
KTKazuhiro Takahashi
Kazuhiro Takahashi
KFKinji Furuya
Kinji Furuya
NONobuhiro Ohkohchi
Nobuhiro Ohkohchi
MHMasato Homma
Masato Homma
Kidney transplant recipients with tacrolimus-based immunosuppressive therapy are often treated with proton-pump inhibitors (PPIs) to prevent gastric ulcer complications. Vonoprazan, a potassium-competitive acid blocker, is a novel PPI possessing different metabolic pathways from conventional PPIs (e.g., omeprazole, lansoprazole and rabeprazole). However, no data are available on the change in blood concentration of tacrolimus after switching rabeprazole, a conventional PPI, to vonoprazan coadministration in the initial period of post-transplantation. This is a retrospective study of 18 kidney transplant recipients. The blood concentration and the concentration to dose (C/D) ratio of tacrolimus were compared before and after switching from rabeprazole to vonoprazan. Impacts of CYP2C19 and CYP3A5 genetic polymorphisms on the drug–drug interaction were also examined. The median (range) trough concentration of tacrolimus was significantly increased from 5.2 (3.6–7.4) to 8.1 (6.1–11.7) ng/mL (p < 0.0005) after switching from rabeprazole to vonoprazan. The C/D ratio of tacrolimus was also significantly increased from 38.1 (16.5–138.1) to 48.9 (26.2–207.2) (p < 0.0005). The percent changes of tacrolimus concentrations and C/D were 65.8% and 41.8%, respectively. CYP2C19 and CYP3A5 genetic polymorphisms did not affect the change in concentration and C/D ratio of tacrolimus. The present study indicates that vonoprazan coadministration increases the tacrolimus concentration regardless of CYP2C19 or CYP3A5 genetic polymorphisms. Thus, frequent monitoring of blood tacrolimus concentration is required when vonoprazan is introduced as an intensive gastric acid blocker in the early phase of post-transplantation.

1 January 2004 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
TUTaro Uchiyama
Taro Uchiyama
TMTetsunori Matsumoto
Tetsunori Matsumoto
YSYoshiharu Suzuki
Yoshiharu Suzuki
MIMasami Ishida
Masami Ishida
TOTakeo Obara
Takeo Obara
TKToshiji Kanayama
Toshiji Kanayama
The effects of endogenous hyaluronan on cervical ripening during pregnancy were examined in rabbits. Hyaluronan of approximately 620 kilodalton (kDa) was detected in the uterine cervix on the 25th and 29th days of pregnancy, while it was not detected in cervix of non-pregnant animals. In addition, low-molecular-weight (less than 191 kDa) hyaluronan was present in cervix at the 29th day of pregnancy. Hyaluronan level in the cervix was lower on the 29th day than on the 25th day of pregnancy, whereas that in serum was significantly higher on the 29th day than on the 25th day of pregnancy. To clarify the physiological functions of endogenous hyaluronan, the effects of hyaluronan (HA600—700), which had approximately equal to endogenous hyaluronan, on uterine cervical tissues and uterine cervical fibroblasts were examined. Rabbits at the 23rd day of pregnancy were administered a vaginal suppository of HA600—700 (20 mg) daily for three days. Promotion of cervical ripening was observed, as well as detachment of collagen fiber bundles, and a reduced density of collagen fiber distribution. Total collagenolytic activity was increased significantly by HA600—700 (1.0 mg/ml) treatment in cultured uterine cervical explants of pregnant rabbits as compared with the untreated group. Moreover, very similar effects of HA600—700 treatment (0.1, 1.0 mg/ml) were observed in cultured uterine cervical fibroblasts. Further, in tissue cultures, but not cell cultures, of pregnant rabbit cervix, prostaglandin E2 (PGE2) production was enhanced by HA600—700 treatment. Therefore, it appears that endogenous hyaluronan is closely concerned with cervical ripening and dilatation in uterine cervix of pregnant rabbits.

26 December 2023 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
YSYoshiharu Suzuki
Yoshiharu Suzuki
SIShingo Ishiguro
Shingo Ishiguro
HSHirokazu Shimada
Hirokazu Shimada
MOMasahiro Ohgami
Masahiro Ohgami
MSMika Suzuki
Mika Suzuki

1 January 1995 in Nephron
Verified
Journal Article
Closed access
KKKazunari Kaneko
Kazunari Kaneko
YSYoshiharu Suzuki
Yoshiharu Suzuki
HWHaruko Watanabe
Haruko Watanabe
YFYutaka Fukuda
Yutaka Fukuda
KYKeijiro Yabuta
Keijiro Yabuta